We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

123:HKEXNewton Resources Ltd Analysis

Data as of 2026-03-07 - not real-time

HK$0.31

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Newton Resources Ltd is trading at HK$0.305, which sits below its 20‑day (HK$0.323) and 50‑day (HK$0.312) simple moving averages but remains above the 200‑day SMA (HK$0.275), suggesting a short‑term pull‑back within a longer‑term bullish backdrop. Technical signals are mixed: RSI is neutral at 45, the MACD histogram is negative and the signal line is labeled “bearish,” while volume has been trending downwards and 30‑day volatility is extremely high at ~91%, indicating a choppy price environment. Fundamentally, the company is under pressure – revenue has collapsed by 38%, margins are deeply negative, ROE is –7%, and the DCF‑derived fair value (HK$0.062) is less than one‑fifth of the current price, flagging a pronounced overvaluation (price‑to‑book 5.6×). Despite a modest cash pile (HK$15.6 M) versus low debt, the high debt‑to‑equity ratio (1.33) and a historic max drawdown of –53% add to downside risk.
Given the confluence of a bearish short‑term technical picture, severe fundamental weaknesses, and an unsustainable valuation gap, the stock appears poised for limited upside in the near term, with greater risk of further declines if broader steel‑sector dynamics remain unfavorable.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price near short‑term support (HK$0.29) with potential bounce
  • Bullish long‑term SMA alignment
  • Low beta indicating limited market‑wide volatility exposure

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent negative margins and revenue decline
  • High valuation relative to DCF and book value
  • Elevated price volatility and decreasing volume

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Fundamental deficits (negative earnings, ROE, and cash flow quality)
  • Significant overvaluation versus intrinsic fair value
  • Historical max drawdown of over 50% and sector cyclicality risk

Key Metrics & Analysis

Financial Health

Revenue Growth-37.80%
Profit Margin-0.84%
ROE-7.08%
ROA-2.23%
Debt/Equity1.33
P/B Ratio5.6
Op. Cash FlowHK$6.9M
Free Cash FlowHK$16.9M

Technical Analysis

TrendBullish
RSI45.3
SupportHK$0.29
ResistanceHK$0.40
MA 20HK$0.32
MA 50HK$0.31
MA 200HK$0.27
MACDBearish
VolumeDecreasing
Fear & Greed Index68.77

Valuation

Fair ValueHK$0.06
Target PriceHK$0.00
GradeOvervalued
TypeValue

Risk Assessment

Beta0.52
Volatility90.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.